AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21559801 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 100
Study 21559801 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 19120041 — intervention group
Group type: EXPERIMENTAL
Intervention: 30‐min supervised self‐study session
Number of subjects: 45
Study 19120041 — intervention group
Group type: COMPARATOR
Intervention: 30‐min neonatal resuscitation session using the Zoe simulator
Number of subjects: 45
Study 16957516 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide treatment
Number of subjects: 20
Study 16957516 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 20
Study 14742371 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine
Number of subjects: 0
Study 14742371 — intervention group
Group type: EXPERIMENTAL
Intervention: Meperidine
Number of subjects: 0
Study 14742371 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl, alfentanil, sufentanil, remifentanil, buprenorphine, naloxone
Number of subjects: 0
Study 11532487 — intervention group
Group type: EXPERIMENTAL
Intervention: Intergel solution (300 mL)
Number of subjects: 281
Study 11532487 — intervention group
Group type: COMPARATOR
Intervention: Lactated Ringer's solution (control)
Number of subjects: 281
Study 9448656 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion SR (100‐300 mg/day)
Number of subjects: 0
Study 9448656 — intervention group
Group type: COMPARATOR
Intervention: Sertraline (50‐200 mg/day)
Number of subjects: 0
Study 9448656 — intervention group
Group type: COMPARATOR
Intervention: Sertraline
Number of subjects: 0
Study 9448656 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion SR
Number of subjects: 0
Study 7939468 — intervention group
Group type: EXPERIMENTAL
Intervention: LHRH agonist (Zoladex)
Number of subjects: 236
Study 7939468 — intervention group
Group type: COMPARATOR
Intervention: Oestrogen (polyoestradiol phosphate, Estradurin)
Number of subjects: 236
Study 3374415 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing medical education (CME) in cardiovascular and cancer medicine
Number of subjects: 31
Study 3374415 — intervention group
Group type: COMPARATOR
Intervention: Control group (no education)
Number of subjects: 31
Study 31720933 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin (40 mg)
Number of subjects: 121
Study 31720933 — intervention group
Group type: COMPARATOR
Intervention: Oxaliplatin (200 mg/m2)
Number of subjects: 121
Study 31666152 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose (0.2 mg) IN SCOP
Number of subjects: 18
Study 31666152 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose (0.4 mg) IN SCOP
Number of subjects: 18
Study 31666152 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 28069654 — intervention group
Group type: EXPERIMENTAL
Intervention: Amikacin
Number of subjects: 80
Study 28069654 — intervention group
Group type: EXPERIMENTAL
Intervention: Kanamycin
Number of subjects: 80
Study 28069654 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic drug monitoring (TDM)
Number of subjects: 80
Study 24664535 — intervention group
Group type: EXPERIMENTAL
Intervention: Endobronchial valves placement
Number of subjects: 0
Study 23168021 — intervention group
Group type: EXPERIMENTAL
Intervention: GPi DBS
Number of subjects: 128
Study 23168021 — intervention group
Group type: EXPERIMENTAL
Intervention: STN DBS
Number of subjects: 128
Study 21742071 — intervention group
Group type: EXPERIMENTAL
Intervention: ronacaleret 200 mg twice daily
Number of subjects: 85
Study 21742071 — intervention group
Group type: EXPERIMENTAL
Intervention: ronacaleret 400 mg once daily
Number of subjects: 85
Study 21742071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 19445553 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone 5 mg and paracetamol 325 mg up to 8 hourly for >/= 6 weeks (group A)
Number of subjects: 150
Study 19445553 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone 5 mg and paracetamol 325 mg up to 8 hourly for >/= 6 weeks (group B)
Number of subjects: 150
Study 19445553 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone/paracetamol therapy (group B)
Number of subjects: 150
Study 19445553 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone/paracetamol therapy (both groups)
Number of subjects: 150
Study 16778460 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide (BP)
Number of subjects: 6
Study 16778460 — intervention group
Group type: EXPERIMENTAL
Intervention: Salicylic acid (SA)
Number of subjects: 6
Study 16778460 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinoic acid (RA)
Number of subjects: 6
Study 16778460 — intervention group
Group type: COMPARATOR
Intervention: None of the agents
Number of subjects: 6
Study 15308882 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan/Hydrochlorothiazide (LOS/HCTZ)
Number of subjects: 0
Study 15308882 — intervention group
Group type: COMPARATOR
Intervention: Ramipril (ACE inhibitor)
Number of subjects: 0
Study 11787984 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg iron daily
Number of subjects: 67
Study 11787984 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg iron daily (enriched with Zn, Cu, Se, vitamin B12, and folate)
Number of subjects: 67
Study 11787984 — intervention group
Group type: COMPARATOR
Intervention: Control group (15 mg iron)
Number of subjects: 67
Study 10193215 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 160
Study 10193215 — intervention group
Group type: EXPERIMENTAL
Intervention: Diamorphine
Number of subjects: 160
Study 10193215 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 160
Study 10193215 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine
Number of subjects: 160
Study 10193215 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 160
Study 8311225 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% propofol emulsion
Number of subjects: 0
Study 8311225 — intervention group
Group type: COMPARATOR
Intervention: 1% propofol emulsion
Number of subjects: 0
Study 3291161 — intervention group
Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 130
Study 3291161 — intervention group
Group type: COMPARATOR
Intervention: RT following chemotherapy
Number of subjects: 130
Study 3291161 — intervention group
Group type: COMPARATOR
Intervention: RT following low dose concurrent irradiation with chemotherapy (LDC‐RT)
Number of subjects: 130
Study 3291161 — intervention group
Group type: COMPARATOR
Intervention: RT concurrently used with chemotherapy
Number of subjects: 130
Study 30791747 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted acupuncture (TA)
Number of subjects: 30
Study 30791747 — intervention group
Group type: COMPARATOR
Intervention: Nontargeted acupuncture (NTA)
Number of subjects: 30
Study 27765707 — intervention group
Group type: EXPERIMENTAL
Intervention: Early physical therapy (initiated within 28 days of the index visit)
Number of subjects: 4723
Study 27765707 — intervention group
Group type: COMPARATOR
Intervention: No early physical therapy
Number of subjects: 4723
Study 25487817 — intervention group
Group type: EXPERIMENTAL
Intervention: DAPT with cilostazol and aspirin or clopidogrel
Number of subjects: 4000
Study 25487817 — intervention group
Group type: COMPARATOR
Intervention: Aspirin or clopidogrel monotherapy
Number of subjects: 4000
Study 25487817 — intervention group
Group type: EXPERIMENTAL
Intervention: DAPT with cilostazol and aspirin
Number of subjects: 4000
Study 25487817 — intervention group
Group type: COMPARATOR
Intervention: Aspirin monotherapy
Number of subjects: 4000
Study 24157403 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and calcium intake (Ex(+)Ca(+))
Number of subjects: 48
Study 24157403 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise no-calcium intake (Ex(+)Ca(−))
Number of subjects: 48
Study 24157403 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake-no-exercise (Ex(−)Ca(+))
Number of subjects: 48
Study 24157403 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise-no-calcium intake (Ex(−)Ca(−))
Number of subjects: 48
Study 22073891 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm acupuncture combined with intra-articular injection of sodium hyaluronate
Number of subjects: 179
Study 22073891 — intervention group
Group type: COMPARATOR
Intervention: Control group (intra-articular injection of sodium hyaluronate only)
Number of subjects: 179
Study 19373470 — intervention group
Group type: EXPERIMENTAL
Intervention: Gd-BOPTA (0.1 mmol/kg body weight)
Number of subjects: 52
Study 19373470 — intervention group
Group type: COMPARATOR
Intervention: Gd-DTPA (0.2 mmol/kg body weight)
Number of subjects: 52
Study 19373470 — intervention group
Group type: EXPERIMENTAL
Intervention: Gd-BOPTA
Number of subjects: 52
Study 19373470 — intervention group
Group type: COMPARATOR
Intervention: Gd-DTPA
Number of subjects: 52
Study 16810138 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-contact, 20-week experimental intervention
Number of subjects: 222
Study 16810138 — intervention group
Group type: COMPARATOR
Intervention: Conventional care control group
Number of subjects: 222
Study 15285333 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid dispersion of glibenclamide in Gelucire 44/14 (Formula 1)
Number of subjects: 6
Study 15285333 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid dispersion of glibenclamide in polyethylene glycol 6000 (PEG 6000) (Formula 2)
Number of subjects: 6
Study 15285333 — intervention group
Group type: COMPARATOR
Intervention: Daonil tablets (Hoechst)
Number of subjects: 6
Study 12738722 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (r‐HuEpo) 40,000 IU s.c. once weekly
Number of subjects: 90
Study 12738722 — intervention group
Group type: EXPERIMENTAL
Intervention: T‐FHX regimen (paclitaxel, fluorouracil, hydroxyurea, radiation)
Number of subjects: 90
Study 12738722 — intervention group
Group type: COMPARATOR
Intervention: Control group (no erythropoietin)
Number of subjects: 90
Study 10957752 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen alone or in combination with progestogens
Number of subjects: 775
Study 10957752 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 775
Study 9003922 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenetix
Number of subjects: 120
Study 9003922 — intervention group
Group type: COMPARATOR
Intervention: Omnipaque
Number of subjects: 120
Study 9003922 — intervention group
Group type: COMPARATOR
Intervention: Iopamiro
Number of subjects: 120
Study 1308305 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.10 mg/kg)
Number of subjects: 60
Study 1308305 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (0.15 mg/kg)
Number of subjects: 60
Study 3914075 — intervention group
Group type: EXPERIMENTAL
Intervention: PAM (pyridine aldoxime methiodide)
Number of subjects: 0
Study 3914075 — intervention group
Group type: EXPERIMENTAL
Intervention: PAC (pralidoxime, pyridine aldoxime methylchloride)
Number of subjects: 0
Study 3914075 — intervention group
Group type: EXPERIMENTAL
Intervention: TMB4 (trimedoxime)
Number of subjects: 0
Study 3914075 — intervention group
Group type: EXPERIMENTAL
Intervention: DMO4 (obidoxime, Toxogonin, LüH6)
Number of subjects: 0
Study 3497885 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-trimoxazole suspension alone
Number of subjects: 8
Study 3497885 — intervention group
Group type: COMPARATOR
Intervention: Co-trimoxazole suspension with pectin-kaolin
Number of subjects: 8
Study 30377210 — intervention group
Group type: EXPERIMENTAL
Intervention: Rose geranium nasal spray
Number of subjects: 40
Study 30851501 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESP)
Number of subjects: 68
Study 30851501 — intervention group
Group type: COMPARATOR
Intervention: Oblique subcostal transversus abdominis block (OSTAP)
Number of subjects: 68
Study 27491758 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental program for Head Start centers
Number of subjects: 0
Study 25998421 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (70ml/day, 6.43mmol nitrate/day)
Number of subjects: 48
Study 25998421 — intervention group
Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (placebo, 70ml/day, 0.07mmol nitrate/day)
Number of subjects: 48
Study 23211565 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal
Number of subjects: 0
Study 23211565 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study 21723064 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-cell stents (Acculink)
Number of subjects: 40
Study 21723064 — intervention group
Group type: COMPARATOR
Intervention: Closed-cell stents (Xact)
Number of subjects: 40
Study 19250841 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative chemoembolization (group A, n = 86)
Number of subjects: 281
Study 19250841 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemoembolization (group B, n = 37)
Number of subjects: 281
Study 19250841 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined preoperative and postoperative chemoembolization (group C, n = 40)
Number of subjects: 281
Study 19250841 — intervention group
Group type: COMPARATOR
Intervention: Nonchemoembolization group (control, n = 118)
Number of subjects: 281
Study 16734393 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based weight-bearing exercise for 30 months
Number of subjects: 160
Study 16734393 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 160
Study 14715856 — intervention group
Group type: EXPERIMENTAL
Intervention: Congenital adrenal hyperplasia (n = 13)
Number of subjects: 53
Study 14715856 — intervention group
Group type: EXPERIMENTAL
Intervention: Familial male‐limited precocious puberty (n = 22)
Number of subjects: 53
Study 14715856 — intervention group
Group type: EXPERIMENTAL
Intervention: Idiopathic short stature (n = 18)
Number of subjects: 53
Study 14715856 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletal advancement
Number of subjects: 53
Study 14715856 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletal delay
Number of subjects: 53
Study 14715856 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletal maturation and hypothalamic‐pituitary‐gonadal axis maturation
Number of subjects: 53
Study 14715856 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothalamic‐pituitary‐gonadal axis maturation
Number of subjects: 53
Study 11715158 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured personal care (intervention group)
Number of subjects: 874
Study 11715158 — intervention group
Group type: COMPARATOR
Intervention: Routine care (comparison group)
Number of subjects: 874
Study 11715158 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 874
Study 9138166 — intervention group
Group type: EXPERIMENTAL
Intervention: High‐energy density amylase digested and then fermented porridge (FAD)
Number of subjects: 87
Study 9138166 — intervention group
Group type: EXPERIMENTAL
Intervention: High‐energy density amylase digested porridge (AMD)
Number of subjects: 87
Study 9138166 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional low‐energy density porridge
Number of subjects: 87
Study 9138166 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 87
Study 8202969 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiographic detection of ulcerated plaques
Number of subjects: 500
Study 2853056 — intervention group
Group type: EXPERIMENTAL
Intervention: enoxacin
Number of subjects: 12
Study 2853056 — intervention group
Group type: EXPERIMENTAL
Intervention: pipemidic acid
Number of subjects: 12
Study 2853056 — intervention group
Group type: EXPERIMENTAL
Intervention: norfloxacin
Number of subjects: 12
Study 2853056 — intervention group
Group type: EXPERIMENTAL
Intervention: ciprofloxacin
Number of subjects: 12
Study 2853056 — intervention group
Group type: EXPERIMENTAL
Intervention: ofloxacin
Number of subjects: 12
Study 31736225 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led electronic communication intervention (Speak for Myself Voice)
Number of subjects: 0
Study 31736225 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 31356468 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP intervention
Number of subjects: 255
Study 29208831 — intervention group
Group type: EXPERIMENTAL
Intervention: Trypan blue dye (0.06%) irrigation in the capsular bag, 0.2 ml injected after cortical cleanup under air.
Number of subjects: 50
Study 29208831 — intervention group
Group type: COMPARATOR
Intervention: Balanced salt solution, 0.2 ml injected in a similar manner as the dye group.
Number of subjects: 50
Study 29208831 — intervention group
Group type: EXPERIMENTAL
Intervention: Trypan blue dye (0.06%) irrigation in the capsular bag.
Number of subjects: 50
Study 29208831 — intervention group
Group type: COMPARATOR
Intervention: Balanced salt solution.
Number of subjects: 50
Study 26215904 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtotal abdominal hysterectomy
Number of subjects: 319
Study 26215904 — intervention group
Group type: COMPARATOR
Intervention: Total abdominal hysterectomy
Number of subjects: 319
Study 22823900 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed bronchoscopy training using a portable, simple simulator
Number of subjects: 20
Study 22823900 — intervention group
Group type: COMPARATOR
Intervention: No manual training (Control)
Number of subjects: 20
Study 22018129 — intervention group
Group type: EXPERIMENTAL
Intervention: Gynol II vaginal gel
Number of subjects: 18
Study 22018129 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethyl cellulose gel (HEC)
Number of subjects: 18
Study 22018129 — intervention group
Group type: COMPARATOR
Intervention: No gel exposure
Number of subjects: 18
Study 18298441 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 0.7 pmol kg(‐1) min(‐1)
Number of subjects: 30
Study 18298441 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 1.2 pmol kg(‐1) min(‐1)
Number of subjects: 30
Study 18298441 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 2.5 pmol kg(‐1) min(‐1)
Number of subjects: 30
Study 18298441 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 30
Study 17215610 — intervention group
Group type: EXPERIMENTAL
Intervention: Bereavement intervention program (10 sessions including Dan-jeon breathing, self-help group activities, and health examination)
Number of subjects: 27
Study 17215610 — intervention group
Group type: COMPARATOR
Intervention: Health examination (control group)
Number of subjects: 27
Study 12588271 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin (SDC 0.5-0.8 ng/mL, n = 572)
Number of subjects: 3782
Study 12588271 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin (SDC 0.9-1.1 ng/mL, n = 322)
Number of subjects: 3782
Study 12588271 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin (SDC >=1.2 ng/mL, n = 277)
Number of subjects: 3782
Study 12588271 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 2611)
Number of subjects: 3782
Study 11369167 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraportal nutrition (PN)
Number of subjects: 20
Study 11369167 — intervention group
Group type: COMPARATOR
Intervention: Systemic nutrition (SN)
Number of subjects: 20
Study 9398695 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral 17 beta‐estradiol (2 mg/day)
Number of subjects: 8
Study 7732287 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual promiscuity
Number of subjects: 4262
Study 7732287 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to Rx
Number of subjects: 4262
Study 7732287 — intervention group
Group type: EXPERIMENTAL
Intervention: Genital infections
Number of subjects: 4262
Study 7732287 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycosis
Number of subjects: 4262
Study 7732287 — intervention group
Group type: EXPERIMENTAL
Intervention: Infertility
Number of subjects: 4262
Study 7732287 — intervention group
Group type: COMPARATOR
Intervention: Benign deteriorations or normality
Number of subjects: 4262
Study 3524647 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmentin
Number of subjects: 748
Study 3524647 — intervention group
Group type: COMPARATOR
Intervention: oxytetracycline
Number of subjects: 748
Study 31073087 — intervention group
Group type: EXPERIMENTAL
Intervention: Domiciliary oxygen therapy (DOXT)
Number of subjects: 30
Study 31073087 — intervention group
Group type: COMPARATOR
Intervention: Placebo (ambient air)
Number of subjects: 30
Study 28196287 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-metal clasp dentures (NMCDs)
Number of subjects: 28
Study 28196287 — intervention group
Group type: COMPARATOR
Intervention: Conventional metal clasp-retained dentures (MCDs)
Number of subjects: 28
Study 23934354 — intervention group
Group type: EXPERIMENTAL
Intervention: Onlay mesh placement
Number of subjects: 80
Study 23934354 — intervention group
Group type: COMPARATOR
Intervention: Sublay mesh placement
Number of subjects: 80
Study 23515219 — intervention group
Group type: EXPERIMENTAL
Intervention: High-salt diet (>200 mEq/day)
Number of subjects: 13
Study 23515219 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-salt diet (<10 mEq/day)
Number of subjects: 13
Study 20881884 — intervention group
Group type: COMPARATOR
Intervention: CR only (n=8)
Number of subjects: 32
Study 20881884 — intervention group
Group type: EXPERIMENTAL
Intervention: CR + moderate-intensity exercise (n=15)
Number of subjects: 32
Study 20881884 — intervention group
Group type: EXPERIMENTAL
Intervention: CR + vigorous-intensity exercise (n=9)
Number of subjects: 32
Study 19809299 — intervention group
Group type: EXPERIMENTAL
Intervention: Side-to-side choledochocholedochostomy with T-tube (n = 99)
Number of subjects: 194
Study 19809299 — intervention group
Group type: COMPARATOR
Intervention: Side-to-side choledochocholedochostomy without T-tube (n = 95)
Number of subjects: 194
Study 16729780 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast 100 microg
Number of subjects: 693
Study 16729780 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast 250 microg
Number of subjects: 693
Study 16729780 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast 500 microg
Number of subjects: 693
Study 16729780 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast (all doses)
Number of subjects: 693
Study 15585624 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin-2 (IL-2) based immunotherapy
Number of subjects: 86
Study 11322841 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate treatment (individualized stress management)
Number of subjects: 60